Chronic myeloid leukemia (CML): prognostic factors and survival analysis
The prognostic value of different factors upon diagnosis of CML was analysed in 45 Philadelphia (Ph1)-positive patients. The median survival was 48 months. Univariate analysis showed 5 poor prognostic factors (male sex, under 45 years-old, bone marrow blasts greater than or equal to 10 percent, bloo...
Main Authors: | Gisele Wally Braga, Maria de Lourdes Lopes Ferrari Chauffaille, José Eduardo Cajado Moncau, Elizabeth Xisto Souto, Maria Regina Regis Silva, José Kerbauy |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Paulista de Medicina
|
Series: | São Paulo Medical Journal |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801996000100005&lng=en&tlng=en |
Similar Items
-
“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report
by: John M. Bennett, et al.
Published: (2015-01-01) -
Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
by: C. B. Almeida, et al.
Published: (2016-11-01) -
Additional chromosome abnormalities in chronic myeloid leukemia
by: Hui-Hua Hsiao, et al.
Published: (2011-02-01) -
A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
by: Gamal Abdul Hamid, et al.
Published: (2014-03-01) -
An unusual association of Morning Glory Syndrome with chronic myeloid leukemia-Philadelphia chromosome
by: Rakesh Panyala, et al.
Published: (2020-01-01)